Your browser doesn't support javascript.
loading
Genetic subclone architecture of tumor clone-initiating cells in colorectal cancer.
Giessler, Klara M; Kleinheinz, Kortine; Huebschmann, Daniel; Balasubramanian, Gnana Prakash; Dubash, Taronish D; Dieter, Sebastian M; Siegl, Christine; Herbst, Friederike; Weber, Sarah; Hoffmann, Christopher M; Fronza, Raffaele; Buchhalter, Ivo; Paramasivam, Nagarajan; Eils, Roland; Schmidt, Manfred; von Kalle, Christof; Schneider, Martin; Ulrich, Alexis; Scholl, Claudia; Fröhling, Stefan; Weichert, Wilko; Brors, Benedikt; Schlesner, Matthias; Ball, Claudia R; Glimm, Hanno.
Afiliação
  • Giessler KM; Department of Translational Oncology, National Center for Tumor Diseases and German Cancer Research Center, Heidelberg, Germany.
  • Kleinheinz K; Division of Theoretical Bioinformatics, German Cancer Research Center, Heidelberg, Germany.
  • Huebschmann D; Division of Theoretical Bioinformatics, German Cancer Research Center, Heidelberg, Germany.
  • Balasubramanian GP; Institute of Pharmacy and Molecular Biotechnology and BioQuant, Heidelberg University, Heidelberg, Germany.
  • Dubash TD; Department of Pediatric Immunology, Hematology and Oncology, University Hospital, Heidelberg, Germany.
  • Dieter SM; Division of Applied Bioinformatics, National Center for Tumor Diseases and German Cancer Research Center, Heidelberg, Germany.
  • Siegl C; German Cancer Consortium, Heidelberg, Germany.
  • Herbst F; Department of Translational Oncology, National Center for Tumor Diseases and German Cancer Research Center, Heidelberg, Germany.
  • Weber S; Department of Translational Oncology, National Center for Tumor Diseases and German Cancer Research Center, Heidelberg, Germany.
  • Hoffmann CM; German Cancer Consortium, Heidelberg, Germany.
  • Fronza R; Department of Translational Oncology, National Center for Tumor Diseases and German Cancer Research Center, Heidelberg, Germany.
  • Buchhalter I; Department of Translational Oncology, National Center for Tumor Diseases and German Cancer Research Center, Heidelberg, Germany.
  • Paramasivam N; Department of Translational Oncology, National Center for Tumor Diseases and German Cancer Research Center, Heidelberg, Germany.
  • Eils R; Department of Translational Oncology, National Center for Tumor Diseases and German Cancer Research Center, Heidelberg, Germany.
  • Schmidt M; Department of Translational Oncology, National Center for Tumor Diseases and German Cancer Research Center, Heidelberg, Germany.
  • von Kalle C; Division of Theoretical Bioinformatics, German Cancer Research Center, Heidelberg, Germany.
  • Schneider M; Institute of Pharmacy and Molecular Biotechnology and BioQuant, Heidelberg University, Heidelberg, Germany.
  • Ulrich A; Division of Theoretical Bioinformatics, German Cancer Research Center, Heidelberg, Germany.
  • Scholl C; Medical Faculty, Heidelberg University, Heidelberg, Germany.
  • Fröhling S; Division of Theoretical Bioinformatics, German Cancer Research Center, Heidelberg, Germany.
  • Weichert W; Heidelberg Center for Personalized Oncology, German Cancer Research Center, Heidelberg, Germany.
  • Brors B; Institute of Pharmacy and Molecular Biotechnology and BioQuant, Heidelberg University, Heidelberg, Germany.
  • Schlesner M; Department of Translational Oncology, National Center for Tumor Diseases and German Cancer Research Center, Heidelberg, Germany.
  • Ball CR; Department of Translational Oncology, National Center for Tumor Diseases and German Cancer Research Center, Heidelberg, Germany.
  • Glimm H; Heidelberg Center for Personalized Oncology, German Cancer Research Center, Heidelberg, Germany.
J Exp Med ; 214(7): 2073-2088, 2017 Jul 03.
Article em En | MEDLINE | ID: mdl-28572216
A hierarchically organized cell compartment drives colorectal cancer (CRC) progression. Genetic barcoding allows monitoring of the clonal output of tumorigenic cells without prospective isolation. In this study, we asked whether tumor clone-initiating cells (TcICs) were genetically heterogeneous and whether differences in self-renewal and activation reflected differential kinetics among individual subclones or functional hierarchies within subclones. Monitoring genomic subclone kinetics in three patient tumors and corresponding serial xenografts and spheroids by high-coverage whole-genome sequencing, clustering of genetic aberrations, subclone combinatorics, and mutational signature analysis revealed at least two to four genetic subclones per sample. Long-term growth in serial xenografts and spheroids was driven by multiple genomic subclones with profoundly differing growth dynamics and hence different quantitative contributions over time. Strikingly, genetic barcoding demonstrated stable functional heterogeneity of CRC TcICs during serial xenografting despite near-complete changes in genomic subclone contribution. This demonstrates that functional heterogeneity is, at least frequently, present within genomic subclones and independent of mutational subclone differences.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Células-Tronco Neoplásicas / Neoplasias Colorretais / Esferoides Celulares / Variações do Número de Cópias de DNA Limite: Animals / Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Células-Tronco Neoplásicas / Neoplasias Colorretais / Esferoides Celulares / Variações do Número de Cópias de DNA Limite: Animals / Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article